2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...
·Î¹öÆ® ÇÒ¸®x¸íÇö¼÷ ºÎºÎ, °¨Ãç¿Ô´ø ºÎºÎÀÇ ºñ¹ÐÀº? (2024-08-05)
Çѱ¹»çȸº¹Áö°øÁ¦È¸, »çȸº¹Áö½Ã¼³ ¿Â¶óÀÎ ¾ÈÀü±³À° ÁøÇà (2024-08-05)
È£¸Å½ÇÀå¾ÖÀÎÁ¾ÇÕº¹Áö°ü-È­È«º´¿ø, Ãë¾à°èÃþ ¹«·á °Ç°­°ËÁø (2024-04-08)
KG ¸ðºô¸®Æ¼, Åä·¹½º EVXÀÇ LFP ¹èÅ͸® ¾ÈÀü¼º ÀÔÁõ (2023-12-22)
¿À¶Ñ±â, ¾óÅ«ÇÏ°Ô Áñ±â´Â ¡®Áö¿ª½Ä ¾óÅ« ±¹¹ä¡¯ Ãâ½Ã (2023-09-05)
°æ·û¼±¼ö ´©¸¥ ¸ðŹü, °æ·ûÇØµµ ¼º°øÇÏ°Ú³× (2014-06-05)
¡®¼± ³ÑÀº ÆÐ¹Ð¸®¡¯ ¾ÈÁ¤È¯, ÆøÅº ¹ß¾ð? ÀÌÇý¿ø ¡®Â¡¯! (2023-11-10)
[ICT] ÁøÈ­ÇÏ´Â ÀΰøÁö´É, ¶Ç ÇѹøÀÇ »ê¾÷ Çõ¸í (2015-12-25)
K-ÆÄ½ºÅ¸ ºê·£µå ÆÄ½ºÅ¸Ä¡¿ä, ¸Ô¹æ À¯Æ©¹ö ¡®¾¥´Ù¡¯ ÇùÂù (2023-10-10)
Áö¿ªÁֹΠÇÔ²²ÇÏ´Â ¡®ÇѰ­¼ö°è ¼öº¯³ìÁö°ü¸® ±³À°°úÁ¤¡¯ ¿î¿µ (2024-07-27)
Visa¡¯s Growth Corporates Working Capital Index Reveals 300%... (2024-11-01)
¹Ìº¸»ó ÅäÁö Á¶È¸ ¹× º¸»ó±Ý ÃßÁ¤ ¼­ºñ½º ¡®¸ù¶¥¡¯ Ãâ½Ã (2024-05-02)
ÇÑÈ­ºÒ²ÉÇÕâ´Ü, Á¤±â¿¬ÁÖȸ ¡®´Ù½Ã, ºÒ²ÉÀ¸·Î¡¯ 2¿ù 6ÀÏ °³ÃÖ (2024-02-06)
MINEOLA, N.Y.--(Business Wire / Korea Newswire) May 24, 2023... (2023-05-24)
½ÅÇѱÝÀ¶±×·ì ¡®2024³âµµ ¼Ò»ó°øÀΡ¤ÀÚ¿µ¾÷ÀÚ »ó»ý±ÝÀ¶ ÆÐŰÁö' (2023-11-23)
¿£¾¾ µµ±¸¸®, ½ÅÇÑÄ«µå Ä÷¡¹ö ½Å¿ë¡¤Ã¼Å©Ä«µå Ãâ½Ã (2023-10-01)
Çѱ¹ÀÇ ºäƼ »ê¾÷°ú ¡®K-Beauty¡¯ (2017-01-15)
CEOs Vote Hybrid Work Flexibility as #1 Driver Underpinning ... (2023-10-12)
ExaGrid Earns Premier 5-Star Rating in 2024 CRN Partner Prog... (2024-04-01)
Æ÷ÅäÀ§Á¬, Ãâ½Ã 3³â ¸¸¿¡ ´©Àû »ç¿ëÀÚ 4000¸¸¸í µ¹ÆÄ (2023-11-03)
Çѱ¹°øÇдëÇб³, Çѱ¹ÀÚµ¿Â÷¿¬±¸¿ø°ú Çп¬Çù·Â Çù¾à (2024-07-07)
¡®°íµù¾öºü4¡¯ ¾çÄ¡½Â °üÀå °Ô½ºÆ® Ã⿬ (2023-12-06)
¹è¿ì ÃÖÇʸ³, °Ç°­½Äǰ Àü¹® ȸ»ç ÇýÀΰǰ­ Àü¼Ó¸ðµ¨ ¹ßŹ (2024-08-09)
°¡¼ö Àå¹ÎÈ£ÀÇ ¡®²Ù´ö¸í¶õÅ©¸²¿ìµ¿¡¯ ³ÃÀå¸é Ä«Å×°í¸® 1À§ (2024-03-23)
ÇÑÈ­»ý¸í, º¸Çè°è¾à´ëÃâ °¡»ê±Ý¸® ÀÎÇÏ (2024-01-19)
       [ÀÌÀü][1]....[620][621][622][623][624][625][626][627][628]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..